Buckner C K, Dea D, Liberati N, Krell R D
Department of Pharmacology, ICI Pharmaceuticals Group, ICI Americas Inc., Wilmington, Delaware 19897.
J Pharmacol Exp Ther. 1991 Apr;257(1):26-34.
The receptors involved in the bronchoconstriction evoked in vivo by intravenous administration to the anesthetized guinea pig of serotonin and serotonin-related agonists have been examined in this study. Animals were pretreated with indomethacin and (+/-)-propranolol to inhibit cyclooxygenase and beta adrenergic receptors, respectively, and pulmonary parameters were obtained with a Buxco pulmonary mechanics computer. Dose-dependent increases in pulmonary resistance and decreases in dynamic lung compliance were produced by serotonin, 2-methyl-serotonin, 5-methoxy-tryptamine, alpha-methyl-serotonin, 5-carboxamidotryptamine, and m-trifluoromethylphenylpiperazine (TFMPP). Responses to all agonists except 2-methyl-serotonin, a selective 5-hydroxytryptamine3 (5-HT3) agonist, were antagonized by the 5-HT2 antagonists, LY53857 and ketanserin. Zaclopride, 1 and 10 mg/kg, a selective 5-HT3 antagonist, blocked responses to 2-methyl-serotonin. A maximally effective dose of LY53857 (1 mg/kg) produced larger shifts of the dose-response curves to serotonin, 5-methoxytryptamine and alpha-methyl-serotonin than did a maximally effective dose of ketanserin (1 mg/kg). Thiorphan, 10 mg/kg, an inhibitor of neutral endopeptidase, potentiated 2-methyl-serotonin and, when studied in the presence of LY53857, also potentiated serotonin, 5-methoxytryptamine and TFMPP. After thiorphan and LY53857, responses to serotonin, but not 5-methoxytryptamine or TFMPP, were blocked by zaclopride. Capsaicin pretreatment of the animals resulted in rightward shifts of the dose-response curves to serotonin, 2-methyl-serotonin and TFMPP, but not to 5-methoxytryptamine or alpha-methyl-serotonin. Potentiation by thiorphan and antagonism by zaclopride of responses to serotonin were still evident after capsaicin pretreatment.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究检测了对麻醉豚鼠静脉注射血清素及血清素相关激动剂在体内诱发支气管收缩所涉及的受体。分别用吲哚美辛和(±)-普萘洛尔预处理动物以抑制环氧化酶和β肾上腺素能受体,并用Buxco肺力学计算机获取肺参数。血清素、2-甲基血清素、5-甲氧基色胺、α-甲基血清素、5-羧酰胺色胺和间三氟甲基苯基哌嗪(TFMPP)可引起肺阻力剂量依赖性增加和动态肺顺应性降低。除2-甲基血清素(一种选择性5-羟色胺3(5-HT3)激动剂)外,所有激动剂的反应均被5-HT2拮抗剂LY53857和酮色林拮抗。选择性5-HT3拮抗剂扎氯普胺1和10mg/kg可阻断对2-甲基血清素的反应。LY53857的最大有效剂量(1mg/kg)比酮色林的最大有效剂量(1mg/kg)使血清素、5-甲氧基色胺和α-甲基血清素的剂量反应曲线有更大的偏移。10mg/kg的中性内肽酶抑制剂硫磷酰胺增强了2-甲基血清素的作用,并且在LY53857存在下进行研究时,也增强了血清素、5-甲氧基色胺和TFMPP的作用。在使用硫磷酰胺和LY53857后,扎氯普胺可阻断对血清素的反应,但不能阻断对5-甲氧基色胺或TFMPP的反应。对动物进行辣椒素预处理导致血清素、2-甲基血清素和TFMPP的剂量反应曲线右移,但对5-甲氧基色胺或α-甲基血清素的曲线无此影响。在辣椒素预处理后,硫磷酰胺的增强作用和扎氯普胺对血清素反应的拮抗作用仍然明显。(摘要截取自250字)